Regulation of Btk function by a major autophosphorylation site within the SH3 domain

Immunity

Volumn 4, Issue 5, 1996, Pages 515-525

  Park, Hyunsun ^a   Wahl, Matthew I ^a   Afar, Daniel E H ^a   Turck, Christoph W ^b   Rawlings, David J ^a   Tam, Christina ^a   Scharenberg, Andrew M ^c   Kinet, Jean Pierre ^c   Witte, Owen N ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; ENZYME INDUCTION; ENZYME MECHANISM; FIBROBLAST; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; X LINKED AGAMMAGLOBULINEMIA;

EID: 0030152357     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80417-3     Document Type: Article

References (57)

1. Aoki, Y., Isselbacher, K.J., and Pillai, S. (1994). Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc. Natl. Acad. Sci. USA 91, 10606-10609.
2. Appleby, M.W., Kerner, J.D., Chien, S., Maliszewski, C.R., Bondada, S., and Perlmutter, R.M. (1995). Involvement of p59 fynT in IL-5 receptor signaling. J. Exp. Med 182, 811-820.
3. Boyle, W.J., van der Geer, P., and Hunter, T. (1991). Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Meth. Enzymol. 201, 110-149.
4. Cambier, J.C., Pleiman, C.M., and Clark, M.R. (1994). Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12, 457-486.
5. Cooper, J.A., and Howell, B. (1993). The when and how of src regulation. Cell 63, 1051-1054.
6. Cory, G.O.C., Lovering, R.C., Hinshelwood, S., MacCarthy-Morrogh, L., Levinsky, R.J., and Kinnon, C. (1995). The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182, 611-615.
7. v-src. Mol. Cell. Biol. 5, 2753-2763.
8. de Weers, M., Mensink, R.G.J., Kraakman, M.E.M., Schuurman, R.K.B., and Hendriks, R.W. (1994). Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Human Mol. Genet. 3, 161-166.
9. Erpel, T., Superti-Furga, G., and Courtneidge, S.A. (1995). Mutational analysis of the src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. EMBO J. 14, 963-975.
10. Feng, S., Chen, J.K., Yu, H., Simon, J.A., and Schreiber, S.L. (1994). Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
11. Ferguson, K.M., Lemmon, M.A., Schlessinger, J., and Sigler, P.B. (1995). Structure of the high affinity complex of inositol triphosphate with a phospholipase c pleckstrin homology domain. Cell 83, 1037-1046.
12. Frangioni, J.V., and Neal, B.G. (1993). Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210, 179-187.
13. Franz, W.M., Berger, P., and Wang, J.Y.J. (1989). Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8, 137-147.
14. Goudreau, N., Cornille, F., Duchesne, M., Parker, F., Tocque, B., Garbay, C., and Roques, B.P. (1994). NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nature Struct. Biol. 1, 898-907.
15. Hanks, S.K., Quinn, A.M., and Hunter, T. (1988). The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52.
16. Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311.
17. Hirai, H., and Varmus, H.E. (1990). Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol. Cell. Biol. 10, 1307-1318.
18. c-src. Mol. Cell. Biol. 5, 1058-1066.
19. Jackson, P., and Baltimore, D. (1989). N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449-456.
20. Jackson, P.K., Paskind, M., and Baltimore, D. (1993). Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-abl. Oncogene 8, 1943-1956.
21. Kawakami, Y., Yao, L., Miura, T., Tsukada, S., Witte, O.N., and Kawakami, T. (1994). Tyrosine phosphorylation and activation of Bruton tyrosine kinase (Btk) upon Fc∈RI cross-linking. Mol. Cell. Biol. 14, 5108-5113.
22. Kazlauskas, A. (1994). Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4, 5-14.
23. Kerner, J.D., Appleby, M.W., Mohr, R.N., Chien, S., Rawlings, D.J., Maliszewski, C.R., Witte, O.N., and Perlmutter, R.M. (1995). Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3, 301-312.
24. Khan, W.N., Alt, F.W., Gerstein, R.M., Malynn, B.A., Larsson, I., Rathbun, G., Davidson, L., Müller, S., Kantor, A.B., Herzenberg, L.A., Rosen, F.S., and Sideras, P. (1995). Defective B cell development and function in Btk-deficient mice. Immunity 3, 283-299.
25. Kinnon, C., Hinshelwood, S., Levinsky, R.J., and Lovering, R.C. (1993). X-linked agammaglobulinemia: gene cloning and future prospects. Immunol. Today 14, 554-558.
26. Knudsen, B.S., Zheng, J., Feller, S.M., Mayer, J.P., Burrell, S.K., Cowburn, D., and Hanafusa, H. (1995). Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J. 14, 2191-2198.
27. Kohda, D., Hatanaka, H., Odaka, M., Mandiyan, V., Ullrich, A., Schlessinger, J., and Inagaki, F. (1993). Solution structure of the SH3 domain of phospholipase C-gamma. Cell 72, 953-960.
28. Konopka, J., and Witte, O.N. (1985). Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol. 5, 3116-3123.
29. Koyama, S., Yu, H., Daigarno, D.C., Shin, T.B., Zydowsky, L.D., and Schreiber, S.L. (1993). Structure of the Pl3K SH3 domain and analysis of the SH3 family. Cell 72, 945-952.
30. c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83, 4228-4232.
31. Li, T., Tsukada, S., Satterthwaite, A., Havlik, M.H., Park, H., Takatsu, K., and Witte, O.N. (1995). Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2, 451-460.
32. Lim, W.A., Richards, F.M., and Fox, R.O. (1994). Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375-379.
33. Lugo, T.G., Pendergast, A.-M., Muller, A.J., and Witte, O.N. (1990). Tyrosine kinase activity and transforming potency of bcr-abl oncogene products. Science 247, 1079-1082.
34. Luo, K., Hurley, T.R., and Sefton, B.M. (1991). Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. Meth. Enzymol. 201, 149-152.
35. Mahajan, S., Fargnoli, J., Burkhardt, A.L., Kut, S.A., Saouaf, S.J., and Bolen, J.B. (1995). Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol. Cell. Biol. 15, 5304-5311.
36. Maignan, S., Guilloteau, J.P., Fromage, N., Arnoux, B., Becquart, J., and Ducruix, A. (1995). Crystal structure of the mammalian Grb2 adaptor. Science 268, 291-293.
37. Matsuda, T., Takahashi-Tezuka, M., Fukada, T., Okuyama, Y., Fujitani, Y., Tsukada, S., Mano, H., Hirai, H., Witte, O.N., and Hirano, T. (1995). Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the IL-6 family of cytokines. Blood 85, 627-633.
38. Mayer, B.J., and Baltimore, D. (1994). Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14, 2883-2894.
39. Muller, A.J., Young, J.C., Pendergast, A.-M., Pondel, M., Landau, N.R., Littman, D.R., and Witte, O.N. (1991). BCR first exon sequences specifically activate Bcr/Abl tyrosine kinase oncogene of Philadelphia chromosome positive human leukemias. Mol. Cell. Biol. 11, 1785-1792.
40. Noble, M.E.M., Musacchio, A., Saraste, M., Courtneidge, S.A., and Wierenga, R.K. (1993). Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 12, 2617-2624.
41. Okada, M., Howell, B.W., Broome, M.A., and Cooper, J.A. (1993). Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. J. Biol. Chem. 268, 18070-18075.
42. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
43. Perlmutter, R.M., Levin, S.D., Appleby, M.W., Anderson, S.J., and Ila-Alberola, J. (1993). Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11, 451-499.
44. Rawlings, D.J., and Witte, O.N. (1995). The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation, and function. Sem. Immunol. 7, 237-246.
45. Rawlings, D.J., Saffran, D.C., Tsukada, S., Largaespada, D.A., Grimaldi, J.C., Cohen, L., Mohr, R.N., Bazan, J.F., Howard, M., Copeland, N.G., Jenkins, N.A., and Witte, O.N. (1993). Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361.
46. Rawlings, D.J., Scharenberg, A.M., Park, H., Wahl, M.I., Lin, S., Kato, R.M., Fluckiger, A.C., Witte, O.N., and Kinet, J.P. (1996). Activation of BTK by a phosphorylation mechanism initiated by Src family kinases. Science 271, 822-825.
47. Saouaf, S.J., Mahajan, S., Rowley, R.B., Kut, S., Fargnoli, J., Burkhardt, A.L., Tsukada, S., Witte, O.N., and Bolen, J.B. (1994).Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91, 9524-9528.
48. Sato, S., Katagiri, T., Takaki, S., Kikuchi, Y., Hitoshi, Y., Yonehara, S., Tsukada, S., Kitamura, D., Watanabe, T., Witte, O., and Takatsu, K. (1994). IL-5 receptor-mediated tyrosine phosphorylation of SH2/ SH3-containing proteins and activation of Btk and JAK2 kinases. J. Exp. Med. 180, 2101-2111.
49. Seidel-Dugan, C., Meyer, B.E., Thomas, S.M., and Brugge, J. (1992). Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12, 1835-1845.
50. Takee, Y., Seiki, M., Fujisawa, J.I., Hoy, P., Yokota, K., Ara, K.I., Yoshida, M., and Arai, N. (1988). SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T cell leukemia virus type I long terminal repeat. Mol. Cell. Biol. 8, 466-472.
51. Terasawa, H., Kohda, D., Hatanaka, H., Tsuchiya, S., Ogura, K., Nagata, K., Ishii, S., Mandiyan, V., Ullrich, A., Schlessinger, J., and Inagaki, F. (1994). Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos. Nature Struct. Biol. 1, 891-897.
52. Thomas, J.D., Sideras, P., Smith, C.I.E., Vorechovsky, I., Chapman, V., and Paul, W.E. (1993). Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-358.
53. Tsukada, S., Saffran, D.C., Rawlings, D.J., Parolini, O., Allen, R.C., Klisak, I., Sparkes, R.S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J.W., Cooper, M.D., Conley, M.E., and Witte, O.N. (1993). Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-290.
54. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarström, L., Kinnon, C., Levinsky, R., Bobrow, M., Smith, C.I.E., and Bentley, D.R. (1993). The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226-233.
55. Wicker, L.S., and Scher, I. (1986). X-linked immune deficiency (xid) of CBA/N mice. Curr. Topics Microbiol. Immunol. 124, 87-101.
56. Yoon, C.H., Lee, J., Jongeward, G.D., and Sternberg, P.W. (1995). Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-Bl. Science 269, 1102-1105.
57. Yu, H., Chens, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W., and Schreiber, S. (1994). Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76, 933-945.